• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯病临床表现的变化:巴西一家学术性三级中心 30 年回顾性调查。

The change in the clinical presentation of Graves' disease: a 30 years retrospective survey in an academic Brazilian tertiary center.

机构信息

Curso de Pós-Graduação em Medicina Interna, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil.

Endocrinologia e Metabolismo, Hospital da Pontifícia Universidade Católica de Campinas (PUC-Campinas), Campinas, SP, Brasil.

出版信息

Arch Endocrinol Metab. 2021 May 18;64(5):514-520. doi: 10.20945/2359-3997000000265.

DOI:10.20945/2359-3997000000265
PMID:34033290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10118967/
Abstract

OBJECTIVE

Graves' disease (GD) is the main cause of hyperthyroidism among adults. It is an autoimmune condition classically marked by the Merserburg Triad (goiter, thyrotoxicosis, and orbitopathy), but the change in presentation of GD over time has rarely been studied. To determine changes in the clinical presentation of patients with GD in the last 30 years.

METHODS

The study evaluated 475 patients diagnosed with GD between 1986 and 2016 in a single center. Patients were evaluated regarding epidemiological aspects, thyroid function, inflammatory activity of the eyes evaluated by the Clinical Activity Score; CAS, severity evaluated by NOSPECS classification and thyroid volume estimated by ultrasonography.

RESULTS

Patients assessment identified an increase in the mean age of diagnosis of GD (p < 0.02), a reduction in thyroid volume (p < 0.001) and less intense orbital involvement from 2007-2016 compared to 1986-2006 (p = 0.04). The number of smoking patients was smaller from 2007 to 2016 (28.7%) than 1986 to 2006 (42.8% p = 0.001). The TSH and TRAb values did not had significant changes.

CONCLUSION

GD presentation appears to be changed in the last years compared to the typical initial presentation. There is a less frequent inflammatory involvement of orbital tissue, smaller goiters, a lower number of smokers and diagnosis at older age.

摘要

目的

Graves 病(GD)是成人甲亢的主要原因。它是一种自身免疫性疾病,经典表现为 Merserburg 三联征(甲状腺肿、甲状腺功能亢进和眼病),但 GD 随时间推移的表现变化很少被研究。为了确定过去 30 年来 GD 患者临床表现的变化。

方法

本研究在单中心评估了 1986 年至 2016 年间诊断为 GD 的 475 例患者。对患者进行流行病学方面、甲状腺功能、眼炎症活动的评估(临床活动评分;CAS)、NOSPECS 分类评估的严重程度和超声检查估计的甲状腺体积的评估。

结果

患者评估发现 GD 的诊断平均年龄增加(p < 0.02),甲状腺体积减少(p < 0.001),2007-2016 年与 1986-2006 年相比,眼眶受累程度较轻(p = 0.04)。2007 年至 2016 年,吸烟患者的数量较 1986 年至 2006 年减少(28.7%比 42.8%,p = 0.001)。TSH 和 TRAb 值没有明显变化。

结论

与典型的初始表现相比,GD 的表现似乎在过去几年发生了变化。眼眶组织炎症受累较少,甲状腺肿较小,吸烟者较少,诊断年龄较大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/10118967/065cca66c959/2359-4292-aem-64-05-0514-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/10118967/065cca66c959/2359-4292-aem-64-05-0514-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/10118967/065cca66c959/2359-4292-aem-64-05-0514-gf01.jpg

相似文献

1
The change in the clinical presentation of Graves' disease: a 30 years retrospective survey in an academic Brazilian tertiary center.格雷夫斯病临床表现的变化:巴西一家学术性三级中心 30 年回顾性调查。
Arch Endocrinol Metab. 2021 May 18;64(5):514-520. doi: 10.20945/2359-3997000000265.
2
The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.促甲状腺激素受体抗体与新诊断的格雷夫斯甲亢患者临床及实验室参数的相关性:来自一家三级转诊中心的经验,该中心纳入了大量促甲状腺激素受体抗体阴性的格雷夫斯甲亢患者。
Endokrynol Pol. 2021;72(1):14-21. doi: 10.5603/EP.a2020.0062. Epub 2020 Sep 18.
3
Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.格雷夫斯病或非格雷夫斯病甲状腺功能亢进症的诊断检测:两种促甲状腺激素受体抗体免疫分析法与甲状腺闪烁显像和超声检查的比较。
Clin Endocrinol (Oxf). 2020 Feb;92(2):169-178. doi: 10.1111/cen.14130. Epub 2019 Dec 5.
4
The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves' disease.血清 DPP4 浓度和活性与 Graves 病患者甲状腺功能亢进症的严重程度呈正相关。
Ann Med. 2023 Dec;55(1):2226910. doi: 10.1080/07853890.2023.2226910.
5
The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.近年来,意大利新诊断的格雷夫斯病的表型比过去更为温和:一项大型观察性纵向研究的结果
J Endocrinol Invest. 2016 Dec;39(12):1445-1451. doi: 10.1007/s40618-016-0516-7. Epub 2016 Jul 27.
6
Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis.促甲状腺素刺激免疫球蛋白生物测定和促甲状腺素结合抑制免疫球蛋白测定在诊断活动性甲状腺毒症患者格雷夫斯病中的性能
Endocr Pract. 2022 May;28(5):502-508. doi: 10.1016/j.eprac.2022.01.007. Epub 2022 Jan 25.
7
The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy.新诊断的格雷夫斯病和活动性格雷夫斯眼病发展中涉及的潜在标志物。
Cytokine. 2020 Mar;127:154998. doi: 10.1016/j.cyto.2020.154998. Epub 2020 Jan 20.
8
Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.甲状腺眼病在 Graves 病伴和不伴眼眶病患者中的认识。
Thyroid. 2019 Apr;29(4):557-562. doi: 10.1089/thy.2018.0665. Epub 2019 Mar 22.
9
Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.55岁以上患者的甲状腺功能亢进症:病因与管理分析
Gerontology. 2003 Sep-Oct;49(5):316-23. doi: 10.1159/000071713.
10
Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.格雷夫斯眼眶病慢性非活动期促甲状腺激素受体抗体水平与疾病严重程度的临床关联
Korean J Ophthalmol. 2015 Aug;29(4):213-9. doi: 10.3341/kjo.2015.29.4.213. Epub 2015 Jul 21.

引用本文的文献

1
The relationship between cholesterol levels and thyroid eye disease.胆固醇水平与甲状腺眼病之间的关系。
Eur Thyroid J. 2025 Feb 3;14(1). doi: 10.1530/ETJ-24-0133. Print 2025 Feb 1.
2
Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.胸腺增生可准确检测到新发 Graves 甲亢,并在恢复甲状腺功能正常后消退。
J Endocrinol Invest. 2024 Oct;47(10):2487-2497. doi: 10.1007/s40618-024-02355-w. Epub 2024 Mar 30.
3
In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features.

本文引用的文献

1
A history of Graves and St. John's.格雷夫斯病和圣约翰草的病史。
Eye (Lond). 2019 Feb;33(2):174-175. doi: 10.1038/s41433-018-0267-0. Epub 2018 Nov 2.
2
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.格雷夫斯眼眶病在欧洲作为一种罕见疾病:欧洲格雷夫斯眼眶病研究小组(EUGOGO)立场声明
Orphanet J Rare Dis. 2017 Apr 20;12(1):72. doi: 10.1186/s13023-017-0625-1.
3
The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.
在格雷夫斯病中,甲状腺自身抗体和超声特征与独特的组织学特征相关。
J Endocrinol Invest. 2023 Aug;46(8):1695-1703. doi: 10.1007/s40618-023-02044-0. Epub 2023 Feb 25.
4
The paths of Graves' disease in the 21st century: precision medicine is closer.21世纪格雷夫斯病的发展路径:精准医学更近一步。
Arch Endocrinol Metab. 2020 Oct 8;64(5):495-497. doi: 10.20945/2359-3997000000304.
近年来,意大利新诊断的格雷夫斯病的表型比过去更为温和:一项大型观察性纵向研究的结果
J Endocrinol Invest. 2016 Dec;39(12):1445-1451. doi: 10.1007/s40618-016-0516-7. Epub 2016 Jul 27.
4
Iodine Nutritional Status in Schoolchildren from Public Schools in Brazil: A Cross-Sectional Study Exposes Association with Socioeconomic Factors and Food Insecurity.巴西公立学校学童的碘营养状况:一项横断面研究揭示了与社会经济因素和粮食不安全的关联。
Thyroid. 2016 Jul;26(7):972-9. doi: 10.1089/thy.2015.0448. Epub 2016 Jun 10.
5
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.2016年欧洲甲状腺协会/欧洲Graves眼病研究组Graves眼病管理指南
Eur Thyroid J. 2016 Mar;5(1):9-26. doi: 10.1159/000443828. Epub 2016 Mar 2.
6
Management of Graves Disease: A Review.格雷夫斯病的治疗:综述。
JAMA. 2015 Dec 15;314(23):2544-54. doi: 10.1001/jama.2015.16535.
7
Assessment of the Effect of Two Distinct Restricted Iodine Diet Durations on Urinary Iodine Levels (Collected over 24 h or as a Single-Spot Urinary Sample) and Na(+)/I(-) Symporter Expression.评估两种不同时长的限碘饮食对尿碘水平(24小时收集或单次晨尿样本)及钠/碘同向转运体表达的影响。
Eur Thyroid J. 2015 Jun;4(2):99-105. doi: 10.1159/000433426. Epub 2015 Jun 11.
8
Effects of increased iodine intake on thyroid disorders.碘摄入增加对甲状腺疾病的影响。
Endocrinol Metab (Seoul). 2014 Sep;29(3):240-7. doi: 10.3803/EnM.2014.29.3.240.
9
Graves' ophthalmopathy: epidemiology and natural history.格雷夫斯眼病:流行病学与自然史
Intern Med. 2014;53(5):353-60. doi: 10.2169/internalmedicine.53.1518.
10
Influence of cigarette smoking on thyroid gland--an update.吸烟对甲状腺的影响——最新进展
Endokrynol Pol. 2014;65(1):54-62. doi: 10.5603/EP.2014.0008.